As of 2025-12-18, the Intrinsic Value of Preveceutical Medical Inc (PREV.CN) is -0.06 CAD. This PREV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Preveceutical Medical Inc is -391.23%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Preveceutical Medical Inc (PREV.CN) is overvalued by 391.23%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.06 - -0.06 | -0.06 | -391.23% |
| DDM - Stable | (0.03) - (0.08) | (0.06) | -377.8% |
| DDM - Multi | (0.02) - (0.03) | (0.02) | -206.1% |
| Market Cap (mil) | 14.95 |
| Beta | -1.03 |
| Outstanding shares (mil) | 747.74 |
| Enterprise Value (mil) | 19.50 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.99% |
| Cost of Debt | 5.00% |
| WACC | 8.84% |